Regulatory Story
Go to market news section View chart   Print
Animalcare Group PLC   -  ANCR   

Dividend Declaration

Released 17:36 25-Sep-2018

RNS Number : 9215B
Animalcare Group PLC
25 September 2018

25 September 2018


Animalcare Group plc

("Animalcare", the "Company" or the "Group")


Dividend declaration for the six months ended 30 June 2018


Animalcare Group plc (AIM: ANCR), the pan-European Animal Health business, is pleased to announce that it will pay an interim dividend of 2.0 pence per ordinary share on 23rd November 2018 to shareholders whose names are on the Register of Members at close of business on 26th October 2018. The ordinary shares will become ex-dividend on 25th October 2018.



For further information, please contact:


Animalcare Group plc

Tel: 01904 487 687

Chris Cardon, Chief Executive Officer

Panmure Gordon (Nominated Adviser & Broker)

Tel: 020 7886 2500

Corporate Finance

Freddy Crossley / Emma Earl

Corporate Broking

James Stearns

Consilium Strategic Communications

Amber Fennell / Chris Welsh / Hendrik Thys



About Animalcare (

Animalcare Group plc is a UK AIM listed veterinary sales, marketing and product development company resulting from the merger of Animalcare and Ecuphar NV.


Post-merger Animalcare is a pan-European animal health company, with a broad geographic footprint. The Company now has direct sales in seven countries (UK, Belgium, Netherlands, Spain, Portugal, Italy and Germany) and exports to approximately 50 markets worldwide.


The enlarged Company has nearly 100 sales representatives and 28 agents operating across Europe and owns 50 licensed drugs, eight vaccines and over 100 care and nutraceutical products.


Animalcare invests in developing its own pharmaceutical products, seeks distribution partnerships and product acquisitions.


For more information see Animalcare Ltd ( and Ecuphar NV (


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.


Dividend Declaration - RNS